ClinConnect ClinConnect Logo
Search / Trial NCT06780514

Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome.

Launched by UNIVERSITY HOSPITAL, GHENT · Jan 13, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cardiopulmonary Exercise Test

ClinConnect Summary

This clinical trial is focused on understanding how well girls aged 8 to 18 with Turner Syndrome can exercise. The main goal is to see if their exercise capacity, measured by a value called VO2 max (which tells us how much oxygen the body can use during exercise), is different from standard values for their age group. The study will also look at how their heart rate and blood pressure change while they are exercising on a special bike designed for this purpose.

To participate in this trial, girls must be diagnosed with Turner Syndrome and be between the ages of 8 and 18. It's important to note that girls who have severe mental impairments that would make it hard for them to complete the exercise tests cannot take part. Those who join the study can expect to undergo a standardized exercise test that will help researchers learn more about the exercise challenges faced by girls with this condition. This information could ultimately lead to better care and support for them in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Turner syndrome girls aged 8-18 years old
  • Exclusion Criteria:
  • Severe mental impairement making it impossible to perform an exercise test

About University Hospital, Ghent

University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.

Locations

Ghent, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported